Advanced Colorectal Cancer
18
Sep
A Randomized, Open-label Phase 3 Study of Amivantamab + FOLFIRI Versus Cetuximab/Bevacizumab + FOLFIRI in Participants With KRAS/NRAS...
Early Stage Colorectal Cancer
18
Sep
Phase III
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers (ASCOLT)
Dukes C and High Risk Dukes B Colorectal Cancers
U...